Bloomin' Brands (BLMN) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for April 23, 2025, with key proposals including board elections, auditor ratification, executive compensation, and a new omnibus incentive plan.
Leadership transitions in 2024 included a new CEO and CFO, with compensation aligned to market benchmarks and performance.
Strategic partnership with Vinci Partners led to the sale of a majority interest in Brazil operations, allowing focus on domestic business.
Voting matters and shareholder proposals
Proposals include electing ten directors, ratifying PricewaterhouseCoopers LLP as auditor, advisory votes on executive compensation and its frequency, approval of the 2025 Omnibus Incentive Compensation Plan, and a shareholder proposal on virtual meetings.
Board recommends voting for all management proposals and against the shareholder proposal on virtual meetings.
Board of directors and corporate governance
Board will reduce from eleven to ten members; all nominees are current or prior directors with diverse backgrounds.
Board diversity matrix and skills matrix provided; three standing committees (Audit, Compensation, Nominating and Corporate Governance) are fully independent.
Board leadership structure includes an independent Chairman; regular self-assessments and committee rotations are encouraged.
Starboard Value LP had two nominees on the board in 2024 under a now-expired agreement.
Latest events from Bloomin' Brands
- Turnaround strategy, board refresh, and pay-for-performance drive key proxy actions.BLMN
Proxy Filing3 Mar 2026 - Annual meeting to vote on directors, compensation, auditor, and key shareholder proposals.BLMN
Proxy Filing3 Mar 2026 - Q4 2025 saw higher revenues, improved traffic, and a turnaround focus, but lower margins.BLMN
Q4 202525 Feb 2026 - Q2 adjusted EPS was $0.51; guidance cut as sales, margins, and traffic declined.BLMN
Q2 20242 Feb 2026 - Q3 sales and earnings declined, with Brazil sale and lower guidance amid ongoing share buybacks.BLMN
Q3 202415 Jan 2026 - Q4 earnings and sales fell as traffic lagged, Brazil was refranchised, and turnaround efforts began.BLMN
Q4 202416 Dec 2025 - Proxy filing covers voting matters and capital structure for the upcoming shareholder meeting.BLMN
Proxy Filing1 Dec 2025 - Flat Q2 sales and margin pressure offset by Brazil divestiture and reaffirmed guidance.BLMN
Q2 202523 Nov 2025 - Q1 2025 revenue and margins declined, but net income rose on Brazil sale and cost controls.BLMN
Q1 202521 Nov 2025